$51.60Pre-market-3.64% · 3M
Moving avg
1W+7.71%
1M+15.16%
3M-3.09%
6M-30.01%
YTD-45.71%
1Y-49.90%
3Y+0.18%
5Y+16.68%
52-week range
$42.2014% of range$109.50
Company health
Value4/6
Growth5/6
Profitability5/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 52% upside to a $78 target
- Analyst consensus is "Buy"
- High return on equity (1482%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$76.43B
Enterprise value
$75.28B
P/E ratio (TTM)
18.44x
P/S ratio (TTM)
3.19x
EV/EBITDA
13.30x
Per share & returns
EPS (TTM)
$2.39
Dividend yield
0.00%
Beta (1Y)
0.58
30-day change
+15.16%
Trading
Volume (24h)
17.56M
Previous close
$51.19
Shares outstanding
1.49B
About Boston Scientific Corporation
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
BSX
Boston Scientific Corporation is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker BSX.
Frequently asked questions
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation (BSX) has a market capitalization of $76.43B.
What is Boston Scientific Corporation's P/E ratio?
Boston Scientific Corporation trades at a price-to-earnings (P/E) ratio of 18.44.
What exchange does BSX trade on?
BSX trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.20-0.36%
$356.65B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.90-0.24%
$289.72B cap
AstraZeneca PLCLON: AZN
£116.54-0.41%
$243.57B cap